Weixiang Lu

4.7k total citations · 1 hit paper
19 papers, 3.0k citations indexed

About

Weixiang Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Weixiang Lu has authored 19 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Weixiang Lu's work include Lung Cancer Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Weixiang Lu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Weixiang Lu collaborates with scholars based in China and United States. Weixiang Lu's co-authors include Jianxing He, Jianfu Li, Wenhua Liang, Hengrui Liang, Caichen Li, Ke Xu, Wei‐jie Guan, Wei Wang, Shiyue Li and Ruchong Chen and has published in prestigious journals such as The Lancet Oncology, Advanced Science and Critical Reviews in Oncology/Hematology.

In The Last Decade

Weixiang Lu

16 papers receiving 2.9k citations

Hit Papers

Cancer patients in SARS-CoV-2 infection: a nationwide ana... 2020 2026 2022 2024 2020 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
    2020 2.9k citations Wenhua Liang, Wei‐jie Guan et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weixiang Lu China 5 2.3k 1.3k 413 361 344 19 3.0k
Caichen Li China 21 3.1k 1.3× 1.9k 1.5× 974 2.4× 670 1.9× 366 1.1× 68 4.9k
Hengrui Liang China 22 3.1k 1.3× 1.9k 1.5× 1.4k 3.3× 683 1.9× 380 1.1× 129 5.2k
Ruchong Chen China 20 2.5k 1.1× 1.8k 1.5× 1.3k 3.2× 387 1.1× 358 1.0× 81 5.1k
Lisa K. Hicks Canada 26 813 0.3× 439 0.3× 157 0.4× 71 0.2× 139 0.4× 112 2.7k
Arjun Gupta United States 25 1.2k 0.5× 484 0.4× 583 1.4× 63 0.2× 343 1.0× 216 3.1k
Qinxin Shen China 3 787 0.3× 526 0.4× 131 0.3× 126 0.3× 125 0.4× 7 1.0k
Tamar H. Taddei United States 33 515 0.2× 319 0.3× 297 0.7× 175 0.5× 96 0.3× 159 4.3k
Kristin Berry United States 31 609 0.3× 542 0.4× 197 0.5× 42 0.1× 117 0.3× 78 3.6k
Camille Maringe United Kingdom 19 1.7k 0.7× 106 0.1× 330 0.8× 154 0.4× 461 1.3× 43 2.5k
Brian D Nicholson United Kingdom 24 789 0.3× 151 0.1× 222 0.5× 128 0.4× 160 0.5× 122 1.9k

Countries citing papers authored by Weixiang Lu

Since Specialization
Citations

This map shows the geographic impact of Weixiang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixiang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixiang Lu more than expected).

Fields of papers citing papers by Weixiang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weixiang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixiang Lu. The network helps show where Weixiang Lu may publish in the future.

Co-authorship network of co-authors of Weixiang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Weixiang Lu. A scholar is included among the top collaborators of Weixiang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixiang Lu. Weixiang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Dan, Weixiang Lu, Zhengming Jin, et al.. (2025). Characteristics of second primary malignancies following bispecific antibodies therapy. Journal for ImmunoTherapy of Cancer. 13(4). e011200–e011200. 3 indexed citations
2.
3.
Lu, Weixiang, Tong Li, Yuzhe Wu, et al.. (2025). Epidemiology and survival of patients with primary lymphoma of bone: a large retrospective cohort study. Annals of Hematology. 104(6). 3345–3358.
4.
Yu, Guopan, Xiaofan Chen, Weixiang Lu, et al.. (2024). Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axis. Blood Cells Molecules and Diseases. 107. 102855–102855. 1 indexed citations
5.
Wang, Yufan, et al.. (2024). Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis. Journal for ImmunoTherapy of Cancer. 12(11). e010064–e010064. 4 indexed citations
6.
Lu, Weixiang, et al.. (2024). LungPath: artificial intelligence-driven histologic pattern recognition for improved diagnosis of early-stage invasive lung adenocarcinoma. Translational Lung Cancer Research. 13(8). 1816–1827. 1 indexed citations
7.
Lu, Weixiang, Ying Yang, & Yang Lei. (2024). Fine-grained image classification method based on hybrid attention module. Frontiers in Neurorobotics. 18. 1391791–1391791. 4 indexed citations
8.
Liu, Jun, Xiuyu Cai, Shunjun Jiang, et al.. (2024). Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort study. BJS Open. 8(2). 1 indexed citations
9.
Jiang, Long, Lan Lan, Yuan Qiu, et al.. (2023). Target genes of N6-methyladenosine regulatory protein ALKBH5 are associated with prognosis of patients with lung adenocarcinoma. Journal of Thoracic Disease. 15(6). 3228–3236. 5 indexed citations
10.
Lu, Weixiang, Guopan Yu, Yanlin Li, et al.. (2023). Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemia. Clinical and Experimental Medicine. 23(8). 4553–4562.
11.
Zhang, Xin, Boxuan Liang, Yuji Huang, et al.. (2023). Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single‐Cell Transcriptomics. Advanced Science. 10(36). e2303753–e2303753. 2 indexed citations
12.
Lu, Weixiang & Lei Yang. (2023). Hot-Rolled Steel Strip Defect Classification Based on ResNet34 Model. 132–135. 1 indexed citations
13.
14.
Lan, Lan, et al.. (2021). A risk score for predicting postoperative complications in non-intubated thoracic surgery. Journal of Thoracic Disease. 13(7). 3960–3968. 4 indexed citations
15.
Zhao, Yi, Bo Cheng, Zisheng Chen, et al.. (2021). Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung cancer: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 160. 103305–103305. 41 indexed citations
16.
Ai, Qing, Hongsheng Deng, Qihua He, et al.. (2021). Early extubation in operating room after single-lung transplantation: a single institutional experience. Annals of Palliative Medicine. 10(4). 4134–4142. 5 indexed citations
17.
18.
Liang, Wenhua, Wei‐jie Guan, Ruchong Chen, et al.. (2020). Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. 21(3). 335–337. 2867 indexed citations breakdown →
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caichen Li Breakdown of academic impact, for papers by Hengrui Liang Breakdown of academic impact, for papers by Ruchong Chen Breakdown of academic impact, for papers by Lisa K. Hicks Breakdown of academic impact, for papers by Arjun Gupta Breakdown of academic impact, for papers by Qinxin Shen Breakdown of academic impact, for papers by Tamar H. Taddei Breakdown of academic impact, for papers by Kristin Berry Breakdown of academic impact, for papers by Camille Maringe Breakdown of academic impact, for papers by Brian D Nicholson
Rankless by CCL
2026